Sponsor

MetaCure (USA), Inc.

Clinical research sponsor

Published trials4
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

4 shown
TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist TherapyNCT01303315 · lead sponsor · 2011-01-01
TERMINATED
The TANTALUS® II for the Treatment of Type 2 DiabetesNCT01303302 · lead sponsor · 2008-04-01
COMPLETED
The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized StudyNCT00547482 · lead sponsor · 2007-09-01
TERMINATED
A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese PatientsNCT00779363 · lead sponsor · 2004-06-01
COMPLETED

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.